Bruce N Kuhlik Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Bruce N Kuhlik.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Bruce N Kuhlik. Bruce N Kuhlik is Exec. V.P. and General Counsel in MERCK SHARP & DOHME CORP. ($MRK) and Exe V-P & Gen Counsel in Merck & Co., Inc. ($MRK) and Exec. V.P. and General Counsel in Merck & Co., Inc. ($MRK).
Latest Insider Trading Transactions of Bruce N Kuhlik
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 08 2014 | MRK | Merck & Co., I ... | Kuhlik Bruce N | Exe V-P & Gen Couns ... | Gift | G | 0.00 | 1,000 | 0 | 127,514 | 128.5 K to 127.5 K (-0.78 %) |
May 13 2014 | MRK | Merck & Co., I ... | Kuhlik Bruce N | Exe V-P & Gen Couns ... | Option Exercise | A | 58.22 | 126,547 | 7,367,566 | 126,547 | |
May 06 2014 | MRK | Merck & Co., I ... | Kuhlik Bruce N | Exe V-P & Gen Couns ... | Option Exercise | M | 0.00 | 9,847 | 0 | 0 | |
May 06 2014 | MRK | Merck & Co., I ... | Kuhlik Bruce N | Exe V-P & Gen Couns ... | Payment of Exercise | F | 58.22 | 5,106 | 297,271 | 127,554 | 132.7 K to 127.6 K (-3.85 %) |
May 06 2014 | MRK | Merck & Co., I ... | Kuhlik Bruce N | Exe V-P & Gen Couns ... | Buy | M | 0.00 | 9,847 | 0 | 132,660 | 122.8 K to 132.7 K (+8.02 %) |
Apr 04 2014 | MRK | Merck & Co., I ... | Kuhlik Bruce N | Exe V-P & Gen Couns ... | Option Exercise | M | 33.49 | 58,825 | 1,970,049 | 0 | |
Apr 04 2014 | MRK | Merck & Co., I ... | Kuhlik Bruce N | Exe V-P & Gen Couns ... | Option Exercise | M | 44.19 | 24,000 | 1,060,560 | 0 | |
Apr 04 2014 | MRK | Merck & Co., I ... | Kuhlik Bruce N | Exe V-P & Gen Couns ... | Option Exercise | M | 44.30 | 62,400 | 2,764,320 | 0 | |
Apr 04 2014 | MRK | Merck & Co., I ... | Kuhlik Bruce N | Exe V-P & Gen Couns ... | Sell | S | 56.38 | 86,400 | 4,871,405 | 121,845 | 208.2 K to 121.8 K (-41.49 %) |
Apr 04 2014 | MRK | Merck & Co., I ... | Kuhlik Bruce N | Exe V-P & Gen Couns ... | Sell | S | 56.50 | 58,825 | 3,323,760 | 208,245 | 267.1 K to 208.2 K (-22.03 %) |
Apr 04 2014 | MRK | Merck & Co., I ... | Kuhlik Bruce N | Exe V-P & Gen Couns ... | Buy | M | 44.19 | 24,000 | 1,060,560 | 267,070 | 243.1 K to 267.1 K (+9.87 %) |
Apr 04 2014 | MRK | Merck & Co., I ... | Kuhlik Bruce N | Exe V-P & Gen Couns ... | Buy | M | 33.49 | 58,825 | 1,970,049 | 243,070 | 184.2 K to 243.1 K (+31.93 %) |
Apr 04 2014 | MRK | Merck & Co., I ... | Kuhlik Bruce N | Exe V-P & Gen Couns ... | Buy | M | 44.30 | 62,400 | 2,764,320 | 184,245 | 121.8 K to 184.2 K (+51.21 %) |
Feb 26 2014 | MRK | Merck & Co., I ... | Kuhlik Bruce N | Exe V-P & Gen Couns ... | Grant | A | 56.18 | 11,642 | 654,048 | 121,845 | 110.2 K to 121.8 K (+10.56 %) |
Dec 18 2013 | MRK | Merck & Co., I ... | Kuhlik Bruce N | Exe V-P & Gen Couns ... | Gift | G | 0.00 | 1,100 | 0 | 109,239 | 110.3 K to 109.2 K (-1.00 %) |
May 08 2013 | MRK | Merck & Co., I ... | Kuhlik Bruce N | Exe V-P & Gen Couns ... | Option Exercise | M | 0.00 | 33,144 | 0 | 0 | |
May 08 2013 | MRK | Merck & Co., I ... | Kuhlik Bruce N | Exe V-P & Gen Couns ... | Option Exercise | M | 33.49 | 117,646 | 3,939,965 | 58,825 | |
May 08 2013 | MRK | Merck & Co., I ... | Kuhlik Bruce N | Exe V-P & Gen Couns ... | Option Exercise | A | 44.98 | 148,148 | 6,663,697 | 148,148 | |
May 08 2013 | MRK | Merck & Co., I ... | Kuhlik Bruce N | Exe V-P & Gen Couns ... | Option Exercise | M | 36.56 | 89,552 | 3,274,021 | 44,776 | |
May 08 2013 | MRK | Merck & Co., I ... | Kuhlik Bruce N | Exe V-P & Gen Couns ... | Option Exercise | M | 23.45 | 42,800 | 1,003,660 | 0 | |
May 08 2013 | MRK | Merck & Co., I ... | Kuhlik Bruce N | Exe V-P & Gen Couns ... | Payment of Exercise | F | 44.98 | 17,186 | 773,026 | 108,385 | 125.6 K to 108.4 K (-13.69 %) |
May 08 2013 | MRK | Merck & Co., I ... | Kuhlik Bruce N | Exe V-P & Gen Couns ... | Buy | M | 0.00 | 33,144 | 0 | 125,571 | 92.4 K to 125.6 K (+35.86 %) |
May 08 2013 | MRK | Merck & Co., I ... | Kuhlik Bruce N | Exe V-P & Gen Couns ... | Sell | S | 45.05 | 249,998 | 11,262,535 | 92,427 | 342.4 K to 92.4 K (-73.01 %) |
May 08 2013 | MRK | Merck & Co., I ... | Kuhlik Bruce N | Exe V-P & Gen Couns ... | Buy | M | 23.45 | 42,800 | 1,003,660 | 342,425 | 299.6 K to 342.4 K (+14.28 %) |
May 08 2013 | MRK | Merck & Co., I ... | Kuhlik Bruce N | Exe V-P & Gen Couns ... | Buy | M | 36.56 | 89,552 | 3,274,021 | 299,625 | 210.1 K to 299.6 K (+42.63 %) |
May 08 2013 | MRK | Merck & Co., I ... | Kuhlik Bruce N | Exe V-P & Gen Couns ... | Buy | M | 33.49 | 117,646 | 3,939,965 | 210,073 | 92.4 K to 210.1 K (+127.29 %) |
Feb 27 2013 | MRK | Merck & Co., I ... | Kuhlik Bruce N | Exe V-P & Gen Couns ... | Grant | A | 42.52 | 12,959 | 551,017 | 91,556 | 78.6 K to 91.6 K (+16.49 %) |
Nov 13 2012 | MRK | Merck & Co., I ... | Kuhlik Bruce N | Exe V-P & Gen Couns ... | Option Exercise | M | 32.72 | 10,000 | 327,200 | 0 | |
Nov 13 2012 | MRK | Merck & Co., I ... | Kuhlik Bruce N | Exe V-P & Gen Couns ... | Option Exercise | M | 23.45 | 30,000 | 703,500 | 42,800 | |
Nov 13 2012 | MRK | Merck & Co., I ... | Kuhlik Bruce N | Exe V-P & Gen Couns ... | Option Exercise | M | 35.09 | 20,880 | 732,679 | 0 | |
Nov 13 2012 | MRK | Merck & Co., I ... | Kuhlik Bruce N | Exe V-P & Gen Couns ... | Option Exercise | M | 34.47 | 500 | 17,235 | 0 | |
Nov 13 2012 | MRK | Merck & Co., I ... | Kuhlik Bruce N | Exe V-P & Gen Couns ... | Sell | S | 44.02 | 61,380 | 2,702,046 | 77,808 | 139.2 K to 77.8 K (-44.10 %) |
Nov 13 2012 | MRK | Merck & Co., I ... | Kuhlik Bruce N | Exe V-P & Gen Couns ... | Buy | M | 34.47 | 500 | 17,235 | 139,188 | 138.7 K to 139.2 K (+0.36 %) |
Nov 13 2012 | MRK | Merck & Co., I ... | Kuhlik Bruce N | Exe V-P & Gen Couns ... | Buy | M | 32.72 | 10,000 | 327,200 | 138,688 | 128.7 K to 138.7 K (+7.77 %) |
Nov 13 2012 | MRK | Merck & Co., I ... | Kuhlik Bruce N | Exe V-P & Gen Couns ... | Buy | M | 35.09 | 20,880 | 732,679 | 128,688 | 107.8 K to 128.7 K (+19.37 %) |
Nov 13 2012 | MRK | Merck & Co., I ... | Kuhlik Bruce N | Exe V-P & Gen Couns ... | Buy | M | 23.45 | 30,000 | 703,500 | 107,808 | 77.8 K to 107.8 K (+38.56 %) |
May 04 2012 | MRK | Merck & Co., I ... | Kuhlik Bruce N | Exe V-P & Gen Couns ... | Option Exercise | A | 39.29 | 168,190 | 6,608,185 | 168,190 | |
May 04 2012 | MRK | Merck & Co., I ... | Kuhlik Bruce N | Exe V-P & Gen Couns ... | Option Exercise | A | 0.00 | 11,708 | 0 | 11,708 | |
Apr 26 2012 | MRK | Merck & Co., I ... | Kuhlik Bruce N | Exe V-P & Gen Couns ... | Option Exercise | M | 0.00 | 13,650 | 0 | 0 | |
Apr 26 2012 | MRK | Merck & Co., I ... | Kuhlik Bruce N | Exe V-P & Gen Couns ... | Payment of Exercise | F | 38.27 | 6,327 | 242,134 | 76,344 | 82.7 K to 76.3 K (-7.65 %) |
Apr 26 2012 | MRK | Merck & Co., I ... | Kuhlik Bruce N | Exe V-P & Gen Couns ... | Buy | M | 0.00 | 13,650 | 0 | 82,671 | 69 K to 82.7 K (+19.78 %) |
Mar 01 2012 | MRK | Merck & Co., I ... | Kuhlik Bruce N | Exe V-P & Gen Couns ... | Grant | A | 38.38 | 10,165 | 390,133 | 68,316 | 58.2 K to 68.3 K (+17.48 %) |
May 06 2011 | MRK | Merck & Co., I ... | Kuhlik Bruce N | Exe V-P & Gen Couns ... | Option Exercise | A | 36.56 | 134,328 | 4,911,032 | 134,328 | |
May 06 2011 | MRK | Merck & Co., I ... | Kuhlik Bruce N | Exe V-P & Gen Couns ... | Option Exercise | A | 0.00 | 9,847 | 0 | 9,847 | |
Mar 01 2011 | MRK | Merck & Co., I ... | Kuhlik Bruce N | Exe V-P & Gen Couns ... | Option Exercise | M | 0.00 | 6,000 | 0 | 0 | |
Mar 01 2011 | MRK | Merck & Co., I ... | Kuhlik Bruce N | Exe V-P & Gen Couns ... | Option Exercise | M | 0.00 | 11,700 | 0 | 0 | |
Mar 01 2011 | MRK | Merck & Co., I ... | Kuhlik Bruce N | Exe V-P & Gen Couns ... | Payment of Exercise | F | 32.19 | 4,253 | 136,904 | 55,749 | 60 K to 55.7 K (-7.09 %) |
Mar 01 2011 | MRK | Merck & Co., I ... | Kuhlik Bruce N | Exe V-P & Gen Couns ... | Payment of Exercise | F | 32.19 | 2,312 | 74,423 | 60,002 | 62.3 K to 60 K (-3.71 %) |
Mar 01 2011 | MRK | Merck & Co., I ... | Kuhlik Bruce N | Exe V-P & Gen Couns ... | Buy | M | 0.00 | 6,000 | 0 | 62,314 | 56.3 K to 62.3 K (+10.65 %) |
Mar 01 2011 | MRK | Merck & Co., I ... | Kuhlik Bruce N | Exe V-P & Gen Couns ... | Buy | M | 0.00 | 11,700 | 0 | 56,314 | 44.6 K to 56.3 K (+26.22 %) |
Feb 24 2011 | MRK | Merck & Co., I ... | Kuhlik Bruce N | Exe V-P & Gen Couns ... | Grant | A | 32.34 | 9,045 | 292,515 | 44,614 | 35.6 K to 44.6 K (+25.43 %) |
Aug 03 2010 | MRK | Merck & Co., I ... | Kuhlik Bruce N | Exe V-P & Gen Couns ... | Option Exercise | M | 0.00 | 15,000 | 0 | 0 | |
Aug 03 2010 | MRK | Merck & Co., I ... | Kuhlik Bruce N | Exe V-P & Gen Couns ... | Payment of Exercise | F | 34.46 | 6,953 | 239,600 | 34,615 | 41.6 K to 34.6 K (-16.73 %) |
Aug 03 2010 | MRK | Merck & Co., I ... | Kuhlik Bruce N | Exe V-P & Gen Couns ... | Buy | M | 0.00 | 15,000 | 0 | 41,568 | 26.6 K to 41.6 K (+56.46 %) |
May 11 2010 | MRK | Merck & Co., I ... | Kuhlik Bruce N | Exe V-P & Gen Couns ... | Option Exercise | A | 33.49 | 176,471 | 5,910,014 | 176,471 | |
May 11 2010 | MRK | Merck & Co., I ... | Kuhlik Bruce N | Exe V-P & Gen Couns ... | Option Exercise | A | 0.00 | 33,144 | 0 | 33,144 | |
Mar 04 2010 | MRK | Merck & Co., I ... | Kuhlik Bruce N | Exe V-P & Gen Couns ... | Option Exercise | M | 0.00 | 4,500 | 0 | 0 | |
Mar 04 2010 | MRK | Merck & Co., I ... | Kuhlik Bruce N | Exe V-P & Gen Couns ... | Payment of Exercise | F | 37.27 | 1,636 | 60,974 | 26,140 | 27.8 K to 26.1 K (-5.89 %) |
Mar 04 2010 | MRK | Merck & Co., I ... | Kuhlik Bruce N | Exe V-P & Gen Couns ... | Buy | M | 0.00 | 4,500 | 0 | 27,776 | 23.3 K to 27.8 K (+19.33 %) |
Feb 02 2010 | MRK | Merck & Co., I ... | Kuhlik Bruce N | Exe V-P & Gen Couns ... | Option Exercise | M | 0.00 | 3,700 | 0 | 0 | |
Feb 02 2010 | MRK | Merck & Co., I ... | Kuhlik Bruce N | Exe V-P & Gen Couns ... | Payment of Exercise | F | 38.18 | 1,345 | 51,352 | 23,276 | 24.6 K to 23.3 K (-5.46 %) |
Feb 02 2010 | MRK | Merck & Co., I ... | Kuhlik Bruce N | Exe V-P & Gen Couns ... | Buy | M | 0.00 | 3,700 | 0 | 24,621 | 20.9 K to 24.6 K (+17.69 %) |
Jan 26 2010 | MRK | Merck & Co., I ... | Kuhlik Bruce N | Exe V-P & Gen Couns ... | Grant | A | 37.72 | 3,261 | 123,005 | 20,921 | 17.7 K to 20.9 K (+18.47 %) |
Nov 05 2009 | MRK | Merck & Co., I ... | Kuhlik Bruce N | Exec. V.P. and Gene ... | Option Exercise | A | 23.45 | 72,800 | 1,707,160 | 0 | |
Nov 05 2009 | MRK | Merck & Co., I ... | Kuhlik Bruce N | Exec. V.P. and Gene ... | Option Exercise | A | 44.30 | 62,400 | 2,764,320 | 0 | |
Nov 05 2009 | MRK | Merck & Co., I ... | Kuhlik Bruce N | Exec. V.P. and Gene ... | Option Exercise | A | 51.02 | 50,000 | 2,551,000 | 0 | |
Nov 05 2009 | MRK | Merck & Co., I ... | Kuhlik Bruce N | Exec. V.P. and Gene ... | Option Exercise | A | 44.19 | 24,000 | 1,060,560 | 0 | |
Nov 05 2009 | MRK | Merck & Co., I ... | Kuhlik Bruce N | Exec. V.P. and Gene ... | Option Exercise | A | 35.09 | 20,880 | 732,679 | 0 | |
Nov 05 2009 | MRK | Merck & Co., I ... | Kuhlik Bruce N | Exec. V.P. and Gene ... | Option Exercise | A | 34.47 | 500 | 17,235 | 0 | |
Nov 05 2009 | MRK | Merck & Co., I ... | Kuhlik Bruce N | Exec. V.P. and Gene ... | Option Exercise | A | 32.72 | 10,000 | 327,200 | 0 | |
Nov 05 2009 | MRK | Merck & Co., I ... | Kuhlik Bruce N | Exec. V.P. and Gene ... | Option Exercise | A | 0.00 | 6,000 | 0 | 0 | |
Nov 05 2009 | MRK | Merck & Co., I ... | Kuhlik Bruce N | Exec. V.P. and Gene ... | Option Exercise | A | 0.00 | 3,700 | 0 | 0 | |
Nov 05 2009 | MRK | Merck & Co., I ... | Kuhlik Bruce N | Exec. V.P. and Gene ... | Option Exercise | A | 0.00 | 13,650 | 0 | 0 | |
Nov 05 2009 | MRK | Merck & Co., I ... | Kuhlik Bruce N | Exec. V.P. and Gene ... | Option Exercise | A | 0.00 | 11,700 | 0 | 0 | |
Nov 05 2009 | MRK | Merck & Co., I ... | Kuhlik Bruce N | Exec. V.P. and Gene ... | Option Exercise | A | 0.00 | 15,000 | 0 | 0 | |
Nov 05 2009 | MRK | Merck & Co., I ... | Kuhlik Bruce N | Exec. V.P. and Gene ... | Option Exercise | A | 0.00 | 4,500 | 0 | 0 | |
Nov 05 2009 | MRK | Merck & Co., I ... | Kuhlik Bruce N | Exec. V.P. and Gene ... | Grant | A | 0.00 | 17,660 | 0 | 0 | -17,660 to 0 (-100.00 %) |
Nov 04 2009 | MRK | MERCK SHARP & ... | Kuhlik Bruce N | Exec. V.P. and Gene ... | Option Exercise | D | 23.45 | 72,800 | 1,707,160 | 0 | |
Nov 04 2009 | MRK | MERCK SHARP & ... | Kuhlik Bruce N | Exec. V.P. and Gene ... | Option Exercise | D | 44.30 | 62,400 | 2,764,320 | 0 | |
Nov 04 2009 | MRK | MERCK SHARP & ... | Kuhlik Bruce N | Exec. V.P. and Gene ... | Option Exercise | D | 51.02 | 50,000 | 2,551,000 | 0 | |
Nov 04 2009 | MRK | MERCK SHARP & ... | Kuhlik Bruce N | Exec. V.P. and Gene ... | Option Exercise | D | 44.19 | 24,000 | 1,060,560 | 0 | |
Nov 04 2009 | MRK | MERCK SHARP & ... | Kuhlik Bruce N | Exec. V.P. and Gene ... | Option Exercise | D | 35.09 | 20,880 | 732,679 | 0 | |
Nov 04 2009 | MRK | MERCK SHARP & ... | Kuhlik Bruce N | Exec. V.P. and Gene ... | Option Exercise | D | 34.47 | 500 | 17,235 | 0 | |
Nov 04 2009 | MRK | MERCK SHARP & ... | Kuhlik Bruce N | Exec. V.P. and Gene ... | Option Exercise | D | 32.72 | 10,000 | 327,200 | 0 | |
Nov 04 2009 | MRK | MERCK SHARP & ... | Kuhlik Bruce N | Exec. V.P. and Gene ... | Option Exercise | D | 0.00 | 6,000 | 0 | 0 | |
Nov 04 2009 | MRK | MERCK SHARP & ... | Kuhlik Bruce N | Exec. V.P. and Gene ... | Option Exercise | D | 0.00 | 3,700 | 0 | 0 | |
Nov 04 2009 | MRK | MERCK SHARP & ... | Kuhlik Bruce N | Exec. V.P. and Gene ... | Option Exercise | D | 0.00 | 13,650 | 0 | 0 | |
Nov 04 2009 | MRK | MERCK SHARP & ... | Kuhlik Bruce N | Exec. V.P. and Gene ... | Option Exercise | D | 0.00 | 11,700 | 0 | 0 | |
Nov 04 2009 | MRK | MERCK SHARP & ... | Kuhlik Bruce N | Exec. V.P. and Gene ... | Option Exercise | D | 0.00 | 15,000 | 0 | 0 | |
Nov 04 2009 | MRK | MERCK SHARP & ... | Kuhlik Bruce N | Exec. V.P. and Gene ... | Option Exercise | D | 0.00 | 4,500 | 0 | 0 | |
Nov 04 2009 | MRK | MERCK SHARP & ... | Kuhlik Bruce N | Exec. V.P. and Gene ... | Sell | D | 0.00 | 17,660 | 0 | 0 | 17.7 K to 0 (-100.00 %) |
Page: 1